It is not the whole story
References PubChem search: Melanotan I afamelanotide PubMed: Melanotan I afamelanotide alpha-MSH PubMed: MC1R melanocortin peptide analogue Research-use notice: Supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law
This dual approach could be particularly beneficial for patients who have struggled to achieve their weight loss and glycemic targets with traditional therapies alone
Design from all business objectives, not just some
At WellLife Medical Centers, we begin with an in-depth metabolic analysis, evaluating markers such as insulin sensitivity, thyroid function, cortisol levels, and nutrient deficiencies to identify the true drivers of weight gain and support lasting weight loss, often incorporating advanced peptide therapy insights where appropriate